Dr. MaryAnne Demasi’s documentary on the criminal activity of the pharmaceutical industry regarding cholesterol-lowering statin drugs sent shock waves through the mainstream media in Australia at the end of 2013. Published in two parts on the popular news show The Catalyst, the pharmaceutical industry complained loudly after the first show, and requested the network not air the second episode, “Heart of the Matter Part 2 – Cholesterol Drug War.”
ABC Australia aired it anyway, but the pharmaceutical influence was apparently too strong, as they later announced that the network would remove the videos from their website because “they breached its impartiality standards.” All copies found on YouTube were also removed.
The cholesterol-lowering statin drug empire continues to crumble. This past Sunday (February 15, 2015) the Sunday Express in the UK published a headline story stating that Oxford professor Dr. Rory Collins, whose research had been used to support putting millions of patients on statin drugs, was reassessing the data behind those studies for possible drug side effects they might have missed previously.
Statins are the world’s best selling pharmaceutical drugs of all time, with no close competitors.
Could the thousands of lawsuits currently being filed in the United States against Lipitor, the best-selling drug in the history of the world, for causing diabetes, be just the tip of the iceberg in terms of serious side effects that are now about to become public?